34 topics with concise breakdowns: definitions, key facts, and class questions.
Medical genetics examines how heredity determines health and the development of pathologies. This section connects fundamental biology — DNA structure and replication, protein biosynthesis, and types of variability — with real clinical medicine.
Here, the development mechanisms and classification of hereditary pathologies are analyzed: monogenic (phenylketonuria, hemoglobinopathies), chromosomal (Down, Patau, Turner, and Klinefelter syndromes), and mitochondrial diseases. A separate block is dedicated to applied technologies: prenatal diagnostic methods, genetic engineering, stem cells, fundamentals of immunogenetics and pharmacogenetics, as well as the genetics of carcinogenesis.
In seminars and colloquiums, instructors most frequently expect a fluent understanding of research methods. You will be expected to analyze pedigrees (genealogical method), decode karyotypes (cytogenetic method), and differentiate the clinical presentation of various chromosomal mutations. Pay special attention to the molecular genetic method and gene therapy, as these form the foundation of modern personalized medicine.
What is the mechanism of action of alkylating agents?
They transfer their alkyl groups (such as methyl, ethyl, or propyl) to biological macromolecules, which leads to direct interaction with DNA and the formation of dangerous intra- and interstrand cross-links.
At what age do hereditary diseases most commonly manifest for the first time?
The highest number of cases (45%) manifest in the pre-pubertal period. Another 25% are detected prenatally, 20% in puberty, and only 10% in individuals older than 20 years.
What are hemoglobinopathies?
This is a separate and very broad group of monogenic diseases. Their development is directly linked to genetic alterations in the normal structure and proper functioning of hemoglobin molecules.
What is the main cause of phenylketonuria development?
The cause is genetically determined deficiency of the hepatic enzyme phenylalanine hydroxylase, which normally ensures the conversion of phenylalanine to tyrosine.
What is the fundamental difference between qualitative and quantitative hemoglobinopathies?
In qualitative disorders (such as sickle cell anemia), the primary structure of the protein itself changes due to a mutation. In quantitative disorders (thalassemia), the protein structure is normal, but the rate of hemoglobin chain synthesis is pathologically reduced.
What is the main clinical manifestation of chromosomal disorders?
The primary clinical manifestation of this group of diseases is invariably the presence of multiple congenital anomalies (MCA) in the patient, rather than isolated anomalies.
Master the entire topic in the "Biology" course
This is a summary. The course covers everything tested in classes and exams.
3,793 pages of study guides across all topics
Assignments and quizzes after every topic — just like in a colloquium